Stocks · Healthcare · Medical - Healthcare Plans
CVS Health Corp. CVS
$86.46 +1.48% Close, Oct 2, 2026 · NYSE · Market cap $110.32B
Inexpensive vs sectorLow risk
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Earnings beat analyst estimates in each of the last 7 quarters (average surprise over the last four: +20.0%).
- Net debt is 4.8× EBITDA, a high level of leverage.
- Revenue over the last four quarters was $415.09B, up 7.4% from a year earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 47%
- EPS growth (TTM, YoY)Bottom 46%
- FCF growth (TTM, YoY)Top 11%
- Revenue growth, 3-year CAGRBottom 43%
- Revenue growth accelerationTop 50%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 26%
- Gross marginBottom 12%
- Operating marginTop 39%
- Cash conversion (OCF / net income)Top 10%
- Accruals (lower is better)Bottom 33%
- Net debt / EBITDA (lower is better)Bottom 14%
- Interest coverTop 34%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 12%
- Free-cash-flow yieldTop 7%
- EBITDA / enterprise valueTop 14%
- Sales / enterprise valueTop 3%
- P/E vs own 5-year history (lower is better)Bottom 28%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 46%
- 6-month returnTop 40%
- 1-year return vs S&P 500Top 50%
- Distance from 52-week highTop 35%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 23%
- Consecutive EPS beatsTop 10%
- Share of analysts rating BuyTop 35%
- Upside to consensus price targetBottom 34%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 6%
- Maximum drawdown, 3 yearsTop 19%
- Beta vs S&P 500 (lower is better)Top 15%
- Net debt / EBITDA (lower is better)Bottom 14%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 7.6% | 7.4% | ↓ |
| EPS growth (YoY) | -45.8% | 5.6% | ↑ |
| Gross margin | 13.8% | 14.2% | ↑ |
| Operating margin | 2.3% | 2.0% | ↓ |
| FCF margin | 1.2% | 2.8% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 7.4% | 7.6% | ↓ | Bottom 47% |
| EPS growth (TTM, YoY) | 5.6% | -45.8% | ↑ | Bottom 46% |
| Gross margin | 14.2% | 13.8% | ↑ | Bottom 12% |
| Operating margin | 2.0% | 2.3% | ↓ | Top 39% |
| Net margin | 1.2% | 1.2% | ↑ | — |
| Free-cash-flow margin | 2.8% | 1.2% | ↑ | — |
| Return on invested capital | 4.1% | — | Top 26% | |
| Revenue growth, 3-year CAGR | 7.6% | — | Bottom 43% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 3.00×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -3.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.1%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -8.2 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 4.85×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 2.7×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 3.10%
- Net buyback yield (TTM)
- -0.38%
- Shareholder yield
- 2.72%
- Share count change, 1 year
- +1.0%
- Share count change, 3-year CAGR
- -0.1%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 7
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +20.0%
- Average 2-day reaction, last 8
- +3.8%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $111.20
- Target vs current price
- +28.6%
- Analysts with a rating
- 41
- Share rating Buy or Strong Buy
- 85%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | +38.0% | -5.1% | -10.5% | -6.5% | — |
| May 6, 2026 | +16.3% | +7.6% | +17.9% | +13.2% | +29.4% |
| Feb 10, 2026 | +9.0% | -0.2% | +3.2% | +0.7% | +14.6% |
| Oct 29, 2025 | +16.8% | -1.9% | -5.0% | -4.5% | +2.0% |
| Jul 31, 2025 | +24.0% | -0.3% | +2.0% | +15.5% | +30.1% |
| May 1, 2025 | +32.4% | +4.1% | +0.1% | -5.9% | -10.6% |
| Feb 12, 2025 | +30.2% | +14.9% | +20.7% | +17.9% | +23.4% |
| Nov 6, 2024 | -24.3% | +11.3% | -2.4% | +4.9% | +1.8% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | $2.58 | $1.87 | +38.0% | $106.10B |
| May 6, 2026 | $2.57 | $2.21 | +16.3% | $106.10B |
| Feb 10, 2026 | $1.09 | $1.00 | +9.0% | $105.69B |
| Oct 29, 2025 | $1.60 | $1.37 | +16.8% | $102.87B |
| Jul 31, 2025 | $1.81 | $1.46 | +24.0% | $98.92B |
| May 1, 2025 | $2.25 | $1.70 | +32.4% | $94.59B |
| Feb 12, 2025 | $1.19 | $0.91 | +30.2% | $97.71B |
| Nov 6, 2024 | $1.09 | $1.44 | -24.3% | $95.43B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 22.9× | 17.3× | 67th | Top 12% |
| P/E (forward) | 10.8× | — | — | — |
| EV / EBITDA | 13.1× | — | — | Top 14% |
| EV / Sales | 0.42× | — | — | Top 3% |
| Free-cash-flow yield | 10.66% | — | — | Top 7% |
| Earnings yield | 4.37% | — | — | Top 12% |
P/E over the past five years
Range 9.9× – 212.1× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +12.5%
- Earnings per share growth (TTM)
- +5.6%
- Change in P/E multiple
- +51.1%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -6.0%
- 200-day average slope (20 days)
- +1.4%
- Distance from 50-day average
- -8.9%
- Distance from 200-day average
- -1.4%
- RSI (14)
- 37.0
- Relative volume
- 1.37×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 27.1%
- Volatility vs own 5-year history
- 47th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.49
- Correlation with S&P 500
- 0.21
- Current drawdown from 1-year high
- -21.8%
- Maximum drawdown, 3 years
- -46.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 8, 2022 | Dec 19, 2024 | -60.5% | 720 days | Not yet recovered |
| May 21, 2021 | Aug 5, 2021 | -10.9% | 52 days | 61 days (Nov 1, 2021) |
| Jan 15, 2021 | Feb 26, 2021 | -10.7% | 28 days | 21 days (Mar 29, 2021) |
| Nov 16, 2020 | Nov 19, 2020 | -10.1% | 3 days | 10 days (Dec 4, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $110.32B
- P/E (TTM)
- 22.9
- EPS, diluted (TTM)
- $3.78
- Revenue (TTM)
- $415.09B
- Dividend yield
- 3.85%
- 52-week range
- $69.51 – $110.68
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $292.11B | $322.47B | $357.78B | $372.81B | $402.07B |
| Gross profit | $52.12B | $54.50B | $54.43B | $51.40B | $55.36B |
| Operating income | $13.31B | $7.95B | $13.74B | $8.52B | $10.38B |
| Net income | $8.00B | $4.31B | $8.34B | $4.61B | $1.77B |
| EPS (diluted) | $5.95 | $3.26 | $6.47 | $3.66 | $1.39 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $95.43B | $97.71B | $94.59B | $98.92B | $102.87B | $105.69B | $100.43B | $106.10B |
| Net income | $87.0M | $1.64B | $1.78B | $1.02B | -$3.98B | $2.94B | $2.94B | $3.00B |
| EPS (diluted) | $0.07 | $1.30 | $1.41 | $0.80 | -$3.13 | $2.30 | $2.30 | $2.31 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $18.27B | $16.18B | $13.43B | $9.11B | $10.64B |
| Capital expenditure | -$2.52B | -$2.73B | -$3.03B | -$2.78B | -$2.83B |
| Free cash flow | $15.74B | $13.45B | $10.39B | $6.33B | $7.81B |
| Dividends paid | -$2.63B | -$2.91B | -$3.13B | -$3.37B | -$3.40B |
| Net share buybacks | $0 | -$3.50B | -$2.01B | -$3.02B | $394.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $13.96B
- Total assets
- $253.77B
- Total liabilities
- $173.87B
- Total debt
- $76.31B
- Net debt
- $64.98B
- Shareholders’ equity
- $79.70B
As of Jun 30, 2026 (filed Aug 5, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Oct 22, 2026 | $0.67 | Nov 2, 2026 |
| Jul 23, 2026 | $0.67 | Aug 3, 2026 |
| Apr 23, 2026 | $0.67 | May 4, 2026 |
| Jan 22, 2026 | $0.67 | Feb 2, 2026 |
| Oct 23, 2025 | $0.67 | Nov 3, 2025 |
| Jul 22, 2025 | $0.67 | Aug 1, 2025 |
| Apr 22, 2025 | $0.67 | May 1, 2025 |
| Jan 23, 2025 | $0.67 | Feb 3, 2025 |
Short interest
- Shares sold short
- 16,123,980
- Days to cover
- 3.14
- Change vs previous report
- -11.0%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jun 7, 2005
- 2-for-1
- Jun 16, 1998
- 2-for-1
- Mar 15, 1989
- 2-for-1
- May 3, 1983
- 2-for-1